Your participation in this survey is crucial in helping us develop the evidence and resources to further the field of Immunization Economics. This survey should take around 20 minutes to complete. Thank you very much for your support. Take the survey here
National governments require economic data on burden of influenza disease, vaccine cost effectiveness , and projected implementation costs. The WHO has developed a value chain of economic analysis tools to cover this need. Read more here
There are few published Budget Impact Analyses (BIAs) compared with cost-effectiveness analyses (CEAs). This study proposes a framework to facilitate the uptake of budget impact of vaccines through CEA information in LMICs. Read more here.
A two-day Methods and Case Studies workshop in Boston seek to develop reference case guidelines for benefit-cost analysis in global health and development. Discussants include Larry Summers, Sue Goldie, and Dean Jamison. Read more here
Health Policy & Planning podcast discusses the importance in understanding detailed cost structure, its relationship with efficiency, and implications for health policy and future planning in immunization programs. Listen to podcast here.
Research helps stakeholders in Bangladesh and other countries make more informed decisions about the true economic burden of childhood diseases and better evaluate investments in vaccines. Read more here
Research teams & policymakers from Indonesia, Tanzania & Vietnam met in Hanoi to discuss costing study designs & cross cutting methods issues for the ICAN project - working towards sustainable immunization financing. Read more here
The Reference Case provides a guide to ensuring that the process of cost estimation is transparent and clear, enhancing the interpretation and use of quality cost data for decision making. See more here.
Health Policy and Planning blogpost examines how detailed understanding of the cost structure of immunization programs can inform policy. Read more here.
Focused on capacity building in applied vaccine economics, cost-effectiveness and finance, TVEE targets audience who are current decision-makers in EPI programs, NiTAGs and partners in GAVI eligible countries. Watch video here
The Value of Vaccination Research Network (VoVRN) is pleased to announce the initiation of a grant-making cycle to fund research on the broader social and economic impacts of vaccination (BSEIV) due Aug 4 2017. See instructions here.
Gavi committed to monitoring externalities of it activities in countries, and on manufacturers and partners. To do so, we are asking the public to help identify externalities of market shaping and how to monitor them. See more here
R4D is seeking to partner with an organization based in Asia, Africa, or Eastern Europe that can provide technical and facilitation assistance for the Learning Network for Countries in Transition. EOI due 7/31/2017. See more here
New analyses revealed costs distribution across budget categories and programmatic activities, and investigated variation of the cost structure by country and site characteristics. See more here
Recent workshop discussed the state of research on the broader social and economic impacts of vaccination (BSEIV), including ongoing and prospective research. Access summary and presentation materials here
Robert Steinglass, Director of the Immunization Center at JSI, delivered a keynote address during the recent workshop: Innovative Approaches to Widening and Deepening Research on the Value of Vaccination. See more here
ICAN research teams from Indonesia, Tanzania, and Vietnam discussed research questions and study designs, which aims to build capacity around generation and use of cost evidence to work toward sustainable immunization financing. See more here
Focused on capacity building in applied vaccine economics, cost-effectiveness and finance, TVEE targets audience who are current decision-makers in EPI programs, NiTAGs and partners in GAVI eligible countries. Read more here
See list here